[go: up one dir, main page]

SE8107101L - Nya antiinflammatoriska och immunreglerade pyridiner - Google Patents

Nya antiinflammatoriska och immunreglerade pyridiner

Info

Publication number
SE8107101L
SE8107101L SE8107101A SE8107101A SE8107101L SE 8107101 L SE8107101 L SE 8107101L SE 8107101 A SE8107101 A SE 8107101A SE 8107101 A SE8107101 A SE 8107101A SE 8107101 L SE8107101 L SE 8107101L
Authority
SE
Sweden
Prior art keywords
pyridines
immune
inflammatory
regulated
new anti
Prior art date
Application number
SE8107101A
Other languages
English (en)
Other versions
SE442110B (sv
Inventor
J G Lombardino
C A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8107101L publication Critical patent/SE8107101L/sv
Publication of SE442110B publication Critical patent/SE442110B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8107101A 1981-06-26 1981-11-27 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur SE442110B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,242 US4371696A (en) 1980-07-14 1981-06-26 Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof

Publications (2)

Publication Number Publication Date
SE8107101L true SE8107101L (sv) 1982-12-27
SE442110B SE442110B (sv) 1985-12-02

Family

ID=23055809

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107101A SE442110B (sv) 1981-06-26 1981-11-27 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur

Country Status (22)

Country Link
US (1) US4371696A (sv)
JP (1) JPS58916A (sv)
AU (1) AU528433B2 (sv)
BE (1) BE890374R (sv)
CH (1) CH648483A5 (sv)
DE (1) DE3215648A1 (sv)
FR (1) FR2508904B2 (sv)
GB (1) GB2100600B (sv)
GR (1) GR75753B (sv)
HK (1) HK67087A (sv)
IE (1) IE51727B1 (sv)
IL (1) IL63699A0 (sv)
IT (1) IT1200569B (sv)
KE (1) KE3458A (sv)
LU (1) LU83827A1 (sv)
MY (1) MY8500351A (sv)
NL (1) NL8105744A (sv)
NZ (1) NZ198215A (sv)
PH (1) PH17742A (sv)
SE (1) SE442110B (sv)
SG (1) SG56084G (sv)
ZA (1) ZA821139B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6179685U (sv) * 1984-10-26 1986-05-27
JPS61207304A (ja) * 1985-03-11 1986-09-13 Toyo Soda Mfg Co Ltd 農園芸用殺菌剤
JPH0445817Y2 (sv) * 1988-09-09 1992-10-28
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
GB1434271A (en) * 1972-09-28 1976-05-05 Squibb & Sons Inc Cephalosporins
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Also Published As

Publication number Publication date
AU528433B2 (en) 1983-04-28
SG56084G (en) 1985-03-08
GB2100600B (en) 1983-09-14
GB2100600A (en) 1983-01-06
LU83827A1 (fr) 1982-05-07
MY8500351A (en) 1985-12-31
FR2508904B2 (fr) 1985-11-29
IT1200569B (it) 1989-01-27
IE51727B1 (en) 1987-03-04
FR2508904A2 (fr) 1983-01-07
NZ198215A (en) 1984-07-06
IL63699A0 (en) 1981-11-30
ZA821139B (en) 1983-01-26
IE812748L (en) 1982-12-26
DE3215648A1 (de) 1983-01-13
SE442110B (sv) 1985-12-02
JPS58916A (ja) 1983-01-06
PH17742A (en) 1984-11-27
CH648483A5 (fr) 1985-03-29
NL8105744A (nl) 1983-01-17
BE890374R (fr) 1982-03-16
US4371696A (en) 1983-02-01
GR75753B (sv) 1984-08-02
IT8219162A0 (it) 1982-01-18
HK67087A (en) 1987-09-25
KE3458A (en) 1984-10-12

Similar Documents

Publication Publication Date Title
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
ES487769A1 (es) Un procedimiento para la preparacion de un nuevo derivado de acido cicloalquilidenmetilfenilacetico
DK571785D0 (da) Mikrobiel cokulturproduktion af propionsyre
ES2058173T3 (es) Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.
SE8107101L (sv) Nya antiinflammatoriska och immunreglerade pyridiner
GB2092133B (en) Pyridine and pyrimidine intermediates
SE7608037L (sv) 2-substituerade oxazolopyridiner
ES2092751T3 (es) Nuevos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzimas proteoliticos y composiciones y metodos de empleo de los mismos.
AR221724A1 (es) Un procedimiento de preparacion de derivados de 1,2-y 1,3-(di-o-n-alquil)-3)o(2)-piperidino glicerol y sus sales de adicion de acidos farmaceuticamente aceptables,utiles como estimulantes no especificos de la inmunidad mediada celularmente
JPS53135958A (en) Substituted phenylacetic acid derivatives and their preparation
BG30928A3 (en) Method for obtaining of 2- /3- aryl- 5- isoxazolin benzoic acids
GB1510042A (en) Alkanoic acids and process for preparing the same
ES8605779A1 (es) Un procedimiento de preparacion del 2,6-dimetil-5-metoxicar-bonil-4-(2-nitrofenil)-1,4-dihidropiridina-3-carboxilato de isobutilo
IT1212723B (it) Derivato dell'acido tiolattico ad attivita'broncosecretogoga.
MC1421A1 (fr) Derives acyles
NZ186138A (en) Production of (+)-2-(5 -n-butyl-4 -hydroxy-2-oxotetrahydrofuran-3 -yl)-2 methyl acetic acid by fermentation
JPS55105643A (en) Novel cyclohexanecarboxylic acid derivative
KR920008000A (ko) 4-또는 5-치환된 피리딘-2-카복실산, 이들의 제조방법 및 약제로서 이들의 용도
JPS54119428A (en) Novel benzoic acid derivative
ES2128972B1 (es) Proceso para producir el acido (+)2-(4-(2-oxociclopentilmetil)fenil) propionico y sus sales
JPS54125660A (en) Oxazole- and thiazolealkanoic acid derivative, its salt and their preparation
PL204360A1 (pl) Sposob wytwarzania estrow kwasu 2-(4-chlorofenoksy)-izomaslowego z poliweglowodanami
BG30325A3 (en) Method for obtaining of thiazolidin- 4- derivatives of acetic acid
JPS53130635A (en) Novel phenyl acetic acid ester derivatives
IT7829412A0 (it) Procedimento per la preparazione di esteri alchilici dell'acido 6-metossi-2-naf-til acetico.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107101-1

Effective date: 19900706

Format of ref document f/p: F